Growth factors for bone growth and repair: IGF, TGFβ and BMP

Bone

Volumn 19, Issue 1 SUPPL., 1996, Pages S1-S12

  Linkhart, Thomas A ^a,b   Mohan, Subburaman ^a,b   Baylink, David J ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c Jerry L Pettis Memorial VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; GROWTH FACTOR; HORMONE; PROTEIN SERINE THREONINE KINASE; RECEPTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA;

BONE CELL; BONE GROWTH; BONE MATRIX; BONE REMODELING; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; FRACTURE HEALING; HUMAN; IMPLANT; MECHANICAL STRESS; NONHUMAN; OSTEOBLAST;

EID: 0030016220     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(96)00138-X     Document Type: Conference Paper

References (96)

1. Amarnani, S., Merriman, H.L., Linkhart, T.A., Baylink, D.J., and Mohan, S. Autocrine regulators of MC3T3-E1 cell proliferation. J Bone Min Res 8:157-165; 1993.
2. Ammann, P., Rizzoli, R., Muller, K., Slosman, D., and Bonjour, J.-P. IGF-I and pamidronate increase bone mineral density in ovariectomized adult rats. Am J Physiol 265:E770-E776; 1993.
3. Andrew, J.G., Hoyland, J., Freemont, A.J., and Marsh, D. Insulin like growth factor gene expression in human fracture callus. Calcif Tiss Int 53:97-102; 1993.
4. Bagi, C.M., Brommage, R., Deleon, L., Adams, S., Rosen, D., and Sommer, A. Benefit of systemically administered rhIGF-I and rhIGF-I/IGFBP-3 on cancellous bone in ovariectomized rats. J Bone Min Res 9:1301-1312; 1994.
5. Baxter, R.C. Insulin-Like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability. Acta Paed Scand [Suppl] 372:107-114; 1991.
6. Baylink, T.M., Beamer, W., Mohan, S., Knutsen, R., Takada, J., Wergedal, J.E., Donahue, L., Douglas, J.A., and Baylink, D.J. Evidence for impaired skeletal growth and impaired bone formation in the short ear mouse, a BMP-5 mutant. J Bone Min Res 9 (Suppl. 1):S249; 1994.
7. Beck, L.S., Amento, E.P., Xu, Y., Deguzman, L., Lee, W.P., Nguyen, T., and Gillett, N.A. TGF-beta 1 induces bone closure of skull defects: temporal dynamics of bone formation in defects exposed to rhTGF-β1. J Bone Min Res 8:753-761; 1993.
8. Benz, D.J., Haussler, M.R., Thomas, M.A., Speelman, B., and Komm, B.S. High affinity androgen binding and androgenic regulation of α1(I)-procollagen and transforming growth factor-β steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells. Endocrinology 128:2723-2730; 1991.
9. Bessho, K. and lizuka, T. Changes in bone inducing activity of bone morphogenetic protein with aging. Ann Chir Gynaecol Suppl 207:49-53; 1993.
10. Bolander, M.E. Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 200:165-170; 1992.
11. Bostrom, M.P., Lane, J.M., Berberian, W.S., Missri, A.A., Tomlin, E., Weiland, A., Doty, S.B., Glaser, D. and Rosen, V.M. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 13:357-367; 1995.
12. Bonewald, L.F. and Dallas, S.L. Role of active and latent transforming growth factor beta in bone formation. J Cell Biochem 55:350-357; 1994.
13. Canalis, E. and Gabbitas, B. Bone morphogenetic protein 2 increases insulin-like growth factor I and II transcripts and polypeptide levels in bone cell cultures. J Bone Min Res 9:1999-2005; 1994.
14. Canalis, E., Pash, J., and Varghese, S. Skeletal growth factors. Crit Rev Eukaryotic Gene Expression 3:155-166; 1993.
15. Centrella, M., Horowitz, M.C., Wozney, J.M., and McCarthy, T.L. Transforming growth factor-β gene family members and bone. Endocrine Reviews 15:27-39; 1994.
16. Chevalley, T., Kanzaki, S., Strong, D.D., Mohan, S., Baylink, D.J., and Linkhart, T.A. Glucocorticoid inhibition of bone formation may in part be mediated by alterations in stimulatory IGF binding protein synthesis. Eur J Endocrinol 134: In Press; 1996.
17. Cook, S.D., Baffes, G.C., Wolfe, M.W., Sampath, T.K., and Rueger, D.C. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orth Rel Res 301:302-312; 1994.
18. Cook, S.D., Baffes, G.G., Wolfe, M.W., Sampath, T.K., Rueger, D.C., and Whitecloud, T.S., 3rd. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg Am 76:827-838; 1994.
19. Critchlow, M.A., Bland, Y.S. and Ashhurst, D.E. The effect of exogenous transforming growth factor-beta 2 on healing fractures in the rabbit. Bone 16:521-527; 1995.
20. Cunningham, N.S., Paralkar, V., and Reddi, A.H. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor β1 mRNA expression. Proc Natl Acad Sci USA 89:11740-11744; 1992.
21. Dallas, S.L., Park-Snyder, S., Miyazono, K., Twardzik, D., Mundy, G.R., and Bonewald, L.F. Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF beta-binding protein. J Biol Chem 269:6815-6821; 1994.
22. Dequeker, J., Mohan, S., Finkelman, R.D., Aerssens, J., and Baylink, D.J. Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor β in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arth Rheumat 36:1702-1708; 1993.
23. Dodds, R.A., Merry, K., Littlewood, A., and Gowen, M. Expression of mRNA for IL 1β, IL6 and TGF β1 in developing human bone and cartilage. J Histochem Cytochem 42:733-744; 1994.
24. D'Souza, R.N., Niederreither, K., and de-Crombrugghe, B. Osteoblast-specific expression of the alpha 2(I) collagen promoter in transgenic mice: correlation with the distribution of TGF-beta 1. J Bone Miner Res 8:1127-1136; 1993.
25. Ebeling, P.R., Jones, J.D., O'Fallon, W.M., Janes, C.H., and Riggs, B.L. Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab 77:1384-1387; 1993.
26. Edwall, D., Prisell, P.T., Levinovitz, A., Jennische, E., and Norstedt, G. Expression of insulin-like growth factor I messenger ribonucleic acid in regenerating bone after fracture: influence of indomethacin. J Bone Min Res 7:207-213; 1992.
27. Elima, K. Osteoinductive proteins. Ann Med 25:395-402; 1993.
28. Ernst, M. and Rodan, G.A. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 127:807-814; 1990.
29. Finkelman, R.D., Bell, N.H., Strong, D.D., Demers, L.M., and Baylink, D.J. Ovariectomy selectively reduces the concentrations of transforming growth factor β in rat bone: implications for estrogen deficiency-associated bone loss. Proc Natl Acad Sci USA 89:12190-12193; 1992.
30. Finkelman, R.D., Eason, A.L., Rakijian, D.R., Tutundzhyan, Y., and Hardesty, R.A. Elevated IGF-II and TGF-ß concentrations in human calvarial bone: potential mechanism for increased graft survival and resistance to osteoporosis. Plast Reconstr Surg 93:732-738; 1994.
31. Finkelman, R.D., Linkhart, T.A., Mohan, S., Lau, K.M.W., Baylink, D.J., and Bell, N.H. Vitamin D deficiency causes a selective reduction in the deposition of transforming growth factor beta in rat bone: possible mechanism for impaired osteoinduction. Proc Natl Acad Sci USA 88:3657-3660; 1991.
32. Gerhart, T.N., Kirker-Head, C.A., Kriz, M.J., Holtrop, M.E., Hennig, G.E., Hipp, J., Schelling, S.H., and Wang, E. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orth Rel Res 293:317-326; 1993.
33. Gitelman, S.E., Kobrin, M.S., Ye, J.Q., Lopez, A.R., Lee, A., and Derynck, R. Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol 126:1595-1609; 1994.
34. Harris, S.E., Bonewald, L.F., Harris, M.A., Sabatini, M., Dallas, S., Feng, J.Q., Ghosh-Choudhury, N., Wozney, J., and Mundy, G.R. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 9:855-863; 1994.
35. Harris, S.E., Harris, M.A., Mahy, P., Wozney, J., Feng, J.Q., and Mundy, G.R. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate 24:204-211; 1994.
36. Herr, G., Wahl, D., and Kusswetter, W. Osteogenic activity of bone morphogenetic protein and hydroxyapatite composite implants. Ann Chir Gynaecol Suppl 207:99-107; 1993.
37. Hill, P.A., Reynolds, J.J., and Meikle, M.C. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Endocrinology 136:124-131; 1995.
38. Ingram, R.T., Bonde, S.K., Riggs, B.L., and Fitzpatrick, L.A. Effects of transforming growth factor beta (TGF beta) and 1,25 dihydroxyvitamin D3 on the function, cytochemistry and morphology of normal human osteoblast-like cells. Differentiation 55:153-163; 1994.
39. Iwasaki, M., Nakahara, H., Nakase, T., Kimura, T., Takaoka, K., Caplan, A.I., and Ono, K. Bone morphogenetic protein 2 stimulates osteogenesis but does not affect chondrogenesis in osteochondrogenic differentiation of periosteum-derived cells. J Bone Miner Res 9:1195-1204; 1994.
40. Joyce, M.E., Jingushi, S., and Bolander, M.E. Transforming growth factor-ß in the regulation of fracture repair. Orthop Clin N Amer 21:199-209; 1990.
41. Kim, G. Y., Lee, H.H., and Cho, S.W. Differential effects of transforming growth factor-beta 1 and bone morphogenetic proteins in cultured rat osteogenic sarcoma and mink lung epithelial cells. Biochem Mol Biol Int 33:253-261; 1994.
42. King, J.A., Marker, P.C., Seung, K.J., and Kingsley, D.M. BMP5 and the molecular, skeletal, and soft-tissue alterations in short ear mice. Dev Biol 166:112-122; 1994.
43. Knutsen, R., Honda, Y., Strong, D.D., Sampath, T.K., Baylink, D.J., and Mohan, S. Regulation of insulin-like growth factor system components by osteogenic protein-1 in human bone cells. Endocrinology 136:857-865; 1995.
44. Knutsen, R., Wergedal, J.E., Sampath, T.K., Baylink, D.J., and Mohan, S. Osteogenic protein-1 stimulates proliferation and differentiation of human bone cells in vitro. Bioch Biophys Res Comm 194:1352-1358; 1993.
45. Koenig, B.B., Cook, J.S., Wolsing, D.H., Ting, J., Tiesman, J.P., Correa, P.E., Olson, C.A., Pecquet, A.L., Ventura, F., Grant, R.A., Chen, G.-X., Wrana, J.L., Massague, J., and Rosenbaum, J.S. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol 14:5961-5974; 1994.
46. Lazowski, D.-A., Fraher, L.J., Hodsman, A., Steer, B., Modrowski, D., and Han, V.K.M. Regional fariation of insulin-like growth factor gene expression in mature rat bone and cartilage. Bone 15:563-576; 1994.
47. Lind, M., Schumacker, B., Soballe, K., Keller, J., Melsen, F., and Bunger, C. Transforming growth factor-β enhances fracture healing in rabbit tibiae. Acta Orthop Scand 64:553-556; 1993.
48. Linkhart, T.A. and MacCharles, D.C. Interleukin-1 (IL-I) stimulates release of insulin-like growth factor-I (IGF-I) from neonatal mouse calvaria by a prostaglandin synthesis dependent mechanism. Endocrinology 131:2297-2305; 1992.
49. Machwate, M., Zerath, E., Holy, X., Pastoureau, P., and Marie, P.J. Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats. Endocrinology 134:1031-1038; 1994.
50. Malpe, R., Baylink, D.J., Sampath, T.K., and Mohan, S. Evidence that human bone cells in culture contain binding sites for osteogenic protein-1. Biochem Biophys Res Commun 201:1140-1147; 1994.
51. 2, growth hormone, and the insulin-like growth factors. J Cellular Physiol 160:163-175; 1994.
52. Miyamoto, S. and Takaoka, K. Bone induction and bone repair by composites of bone morphogenetic protein and biodegradable synthetic polymers. Ann Chir Gynaecol Suppl 207:69-75; 1993.
53. Miyazono, H., Ichijo, H., and Heldin, C.-H. Transforming growth factor-ß: latent forms, binding proteins and receptors. Growth Factors 8:11-22; 1993.
54. Mochizuki, H., Hakeda, Y., Wakatsuki, N., Usui, N., Akashi, S., Sato, T., Tanaka, K., and Kumegawa, M. Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology 131:1075-1080; 1992.
55. Mohan, S. IGF binding proteins in bone cell regulation. Growth Regul 3:67-70; 1993.
56. Mohan, S. and Baylink, D.J. Bone growth factors. Clin Orth Rel Res 263:30-48; 1991.
57. Mohan, S., Nakao, Y., Honda, Y., Landale, E., Leser, U., Dony, C., Lang, K. and Baylink, D.J. Studies on the mechanism by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 270:20424-20431; 1995.
58. Mueller, K., Cortesi, R., Modrowski, D., and Marie, P.J. Stimulation of trabecular bone formation by insulin-like growth factor I in adult ovariectomized rats. Am J Physiol 267:E1-E6; 1994.
59. Mundy, G.R. Factors which stimulate bone growth in vivo. Growth Regul 3:124-128; 1993.
60. Muschler, G.F., Hyodo, A., Manning, T., Kambic, H., and Easley, K. Evaluation of human bone morphogenetic protein 2 in a canine spinal fusion model. Clin Orthop 308:229-240; 1994.
61. Nagai, M. and Ota, M. Pulsating electromagnetic field stimulates mRNA expression of bone morphogenetic protein-2 and -4. J Dent Res 73:1601-1605; 1994.
62. Nakase, T., Nomura, S., Yoshikawa, H., Hashimoto, J., Hirota, S., Kitamura, Y., Oikawa, S., Ono, K., and Takaoka, K. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res 9:651-659; 1994.
63. Nakashima, M. Induction of dentin formation on canine amputated pulp by recombinant human bone morphogenetic proteins (BMP)-2 and -4. J Dent Res 73:1515-1522; 1994.
64. Nicolas, V., Mohan, S., Honda, Y., Prewett, A., Finkelman, R.D., Baylink, D.J., and Farley, J.R. An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone. Calcif Tiss Int 57:206-212; 1995.
65. Nicolas, V., Prewett, A., Bettica, P., Mohan, S., Finkelman, R.D., Baylink, D.J., and Farley, J.R. Age-related decreases in insulin-like growth factor-I and transforming growth factor-β in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab 78:1011-1016; 1994.
66. Nielsen, H.M., Andreassen, T.T., Ledet, T. and Oxlund, H. Local injection of TGF-β increases the strength of tibial fractures in the rat. Acta Orthop Scand 65:37-41; 1994.
67. Okazaki, R., Riggs, B.L., and Conover, C.A. Glucocorticoid regulation of insulin-like growth factor-binding protein expression in normal human osteoblast-like cells. Endocrinology 134:126-132; 1994.
68. Oursler, M.J., Cortese, C., Keeting, P., Anderson, M.A., Bonde, S.K., Riggs, B.L., and Spelsberg, T.C. Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17 ß-estradiol and parathyroid hormone. Endocrinology 129:3313-3320; 1991.
69. Pajamaki, K.J., Andersson, O.H., Lindholm, T.S., Karlsson, K.H., Yli-Urpo, A., and Happonen, R.P. Effect of bovine bone morphogenetic protein and bioactive glass on demineralized bone matrix grafts in the rat muscular pouch. Ann Chir Gynaecol Suppl 207:155-161; 1993.
70. Prisell. P.T., Edwall, D., Lindblad, J.B., Levinovitz, A., and Norstedt, G. Expression of insulin-like growth factors during bone induction in rat. Calcif Tiss Int 53:201-205; 1993.
71. Raab-Cullen, D.M., Thiede, M.A., Peterson, D.N., Kimmel, D.B., and Recker, R.R. Mechanical loading stimulates rapid changes in periosteal gene expression. Calcif Tiss Int 55:473-478; 1994.
72. Reddi, A.H. and Cunningham, N.S. Initiation and promotion of bone differentiation by bone morphogenetic proteins. J Bone Miner Res 8 (Suppl. 2):S499-S502; 1993.
73. Rosen, C.J., Donahue, L.R. and Hunter, S. Insulin-like growth factors and bone: the osteoporosis connection. Proc Soc Exptl Biol Med 206:83-102; 1994
74. Rosen, D., Miller, S.C., DeLeon, E., Thompson, A.Y., Bentz, H., Mathews, M., and Adams, S. Systemic administration of recombinant transforming growth factor beta 2 (rTGF-β2) stimulates parameters of cancellous bone formation in juvenile and adult rats. Bone 15:355-359; 1994.
75. Sandberg, M.M., Aro, H.T., and Vuorio, E.I. Gene expression during bone repair. Clin Orth Rel Res 289:292-312; 1993.
76. 3 increases expression of insulin-like growth factor binding protein-4 (IGFBP-4) in human osteoblast-like cells in vitro and elevates IGFBP-4 serum levels in vivo. J Clin Endocrinol Metabol 77:1190-1197; 1993.
77. Shimasaki, S. and Ling, N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog in Growth Factor Res 3:243-266; 1992.
78. Spencer, E.M., Liu, C.C., Si, E.G.C., and Howard, G.A. In vivo actions of insulin-like growth factor-1 (IGF-I) on bone formation and resorption in rats. Bone 12:21-26; 1991
79. Storm, E.E., Huynh, T.V., Copeland, N.G., Jenkins, N.A., Kingsley, D.M., and Lee, S.-J. Limb alterations in brachypodism mice due to mutations in a new member of the TGFβsuperfamily. Nature 368:639-643; 1994.
80. Strong, D.D., Beachler, A.L., Wergedal, J.W., and Linkhart, T.A. Insulin like growth factor II and transforming growth factor beta regulate Type I procollagen message levels in human osteoblast-like cells in vitro. J Bone Min Res 6:15-23; 1990.
81. Takada, Y., Baylink, D.J., Linkhart, T.A., Edwall, E., Kumegawa, M., and Mohan, S. Calcitropic hormones and growth factors regulate osteoclast survival in vitro. J Bone Min Res 9 (Suppl. 1):S311; 1994.
82. Takeda, K., Oida, S., Ichijo, H., Iimura, T., Maruoka, Y., Amagasa, T., and Sasaki, S. Molecular cloning of rat bone morphogenetic protein (BMP) Type 1A receptor and its expression during ectopic bone formation induced by BMP. Bioch Biophys Res Comm 204:203-209; 1994.
83. Talley-Ronsholdt, D.J., Lajiness, E., and Nagodawithana, K. Transforming growth factor-beta inhibition of mineralization by neonatal rat osteoblasts in monolayer and collagen gel culture. In Vitro Cell Dev Biol 31:274-282; 1995.
84. ten Dijke, P., Franzien, P., Yamashita, H., Ichijo, H., Heldin, C.-H., and Miyazono, K. Serine/threonine kinase receptors. Prog Growth Factor Res 5:55-72; 1994.
85. ten Dijke, P., Yamashita, H., Sampath, T.K., Reddi, A.H., Estevez, M., Riddle, D.L., Ichijo, H., Heldin, C.-H., and Miyazono, K. Identification of Type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 269:16985-16988; 1994.
86. ten Dijke, P., Miyazono, K. and Heldin, C.-H. Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr Op Cell Biol 8:139-145; 1996
87. Thaller, S.R., Dart, A., and Tesluk, H. The effects of insulin-like growth factor-1 on critical-size calvarial defects in Sprague-Dawley rats. Ann Plast Surg 31:429-433; 1993.
88. Thissen, J.P., Ketelslegers, J.M., and Underwood, L.E. Nutritional regulation of the insulin-like growth factors. Endocr Rev 15:80-101; 1994.
89. Urist, M.R.. The search for and discovery of bone morphogenetic protein (BMP),. Urist, M.R., O'Conner, B.T. and Burwell, R.G. eds. Bone grafts, derivatives and substitutes. London: Butterworth Heineman; 1994; 315, 362.
90. Wahl, S.M. Transforming growth factor ß: the good, the bad, and the ugly. J Exptl Med 180:1587-1590; 1994.
91. 3. Metabolism 41:42-48; 1992.
92. Wozney, J.M. The bone morphogenetic protein family and osteogenesis. Mol Rep Dev 32:160-167; 1992.
93. Wrana, J.L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. Mechanism of activation of the TGF-β receptor. Nature 370:341-346; 1994.
94. Yan, J., Xiang, W., Baolin, L., and White, F.H. Early histologic response to titanium implants complexed with bovine bone morphogenetic protein. J Prosthet Dent 71:289-294; 1994.
95. Yee, J.A., Yan, L., Dominguez, J.C., Allan, E.H., and Martin, T.J. Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells. J Cell Physiol 157:528-534; 1993.
96. Zheng, M.H., Wood, D.J., Wysocki, S., Papidimitriou, J.M., and Wang, E.A. Recombinant human bone morphogenetic protein-2 enhances expression of interleukin-6 and transforming growth factor-ß1 genes in normal human osteoblast-like cells. J Cell Physiol 159:76-82; 1994.